James M. Woolven

2.9k total citations · 1 hit paper
13 papers, 2.0k citations indexed

About

James M. Woolven is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, James M. Woolven has authored 13 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Hematology. Recurrent topics in James M. Woolven's work include Protein Degradation and Inhibitors (3 papers), Computational Drug Discovery Methods (2 papers) and Multiple Myeloma Research and Treatments (2 papers). James M. Woolven is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Computational Drug Discovery Methods (2 papers) and Multiple Myeloma Research and Treatments (2 papers). James M. Woolven collaborates with scholars based in United Kingdom, Ireland and United States. James M. Woolven's co-authors include Ian D. Wall, Mika Lindvall, Martha S. Head, C. Webster Andrews, Brian Clarke, Gregory L. Warren, Catherine E. Peishoff, Giovanna Tedesco, Neysa Nevins and Simon F. Semus and has published in prestigious journals such as Journal of Cell Science, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

James M. Woolven

13 papers receiving 2.0k citations

Hit Papers

A Critical Assessment of Docking Programs and Scoring Fun... 2005 2026 2012 2019 2005 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Critical Assessment of Docking Programs and Scoring Functions
    2005 1.3k citations Gregory L. Warren, C. Webster Andrews et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Woolven United Kingdom 11 1.3k 923 443 229 195 13 2.0k
Ian D. Wall United Kingdom 14 1.4k 1.0× 1.0k 1.1× 330 0.7× 280 1.2× 122 0.6× 26 1.9k
Pieter F. W. Stouten United States 20 1.4k 1.1× 696 0.8× 313 0.7× 306 1.3× 185 0.9× 54 2.1k
Alexander Hillisch Germany 28 1.4k 1.1× 705 0.8× 458 1.0× 255 1.1× 159 0.8× 57 2.8k
Natasja Brooijmans United States 24 1.8k 1.3× 666 0.7× 733 1.7× 220 1.0× 208 1.1× 42 2.6k
Renée L. DesJarlais United States 28 1.5k 1.1× 768 0.8× 727 1.6× 230 1.0× 264 1.4× 61 2.5k
Oliver Korb United Kingdom 17 1.4k 1.0× 922 1.0× 461 1.0× 285 1.2× 162 0.8× 34 2.1k
Anne Cleasby United Kingdom 23 2.0k 1.5× 614 0.7× 441 1.0× 359 1.6× 451 2.3× 37 2.8k
Olivier Spérandio France 25 1.7k 1.2× 1.2k 1.3× 438 1.0× 195 0.9× 175 0.9× 52 2.5k
Gianni Chessari United Kingdom 24 2.0k 1.5× 1.2k 1.3× 656 1.5× 462 2.0× 207 1.1× 35 2.9k
Peichen Pan China 28 2.1k 1.6× 1.1k 1.2× 337 0.8× 360 1.6× 376 1.9× 88 3.1k

Countries citing papers authored by James M. Woolven

Since Specialization
Citations

This map shows the geographic impact of James M. Woolven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Woolven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Woolven more than expected).

Fields of papers citing papers by James M. Woolven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Woolven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Woolven. The network helps show where James M. Woolven may publish in the future.

Co-authorship network of co-authors of James M. Woolven

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Woolven. A scholar is included among the top collaborators of James M. Woolven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Woolven. James M. Woolven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lucas, Simon C. C., Stephen J. Atkinson, Chun‐wa Chung, et al.. (2021). Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors. Journal of Medicinal Chemistry. 64(15). 10711–10741. 20 indexed citations
2.
Graves, Alan P., Ian D. Wall, James M. Woolven, et al.. (2017). A Perspective on Water Site Prediction Methods for Structure Based Drug Design. Current Topics in Medicinal Chemistry. 17(23). 2599–2616. 9 indexed citations
3.
Woolven, James M., Ken Saunders, Karen D. Simpson, et al.. (2013). A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function. Journal of Cell Science. 126(Pt 14). 3159–69. 19 indexed citations
4.
Alder, Catherine M., Amanda Campbell, Angela M. Deakin, et al.. (2013). Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy. ACS Medicinal Chemistry Letters. 4(10). 948–952. 16 indexed citations
5.
Young, Robert J., W. Alderton, Paul Beswick, et al.. (2011). Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(10). 3037–3040. 2 indexed citations
6.
Chung, Chun‐wa, Anthony Dean, James M. Woolven, & Paul Bamborough. (2011). Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery. Journal of Medicinal Chemistry. 55(2). 576–586. 145 indexed citations
7.
Barnett, Heather, Diane M. Coe, Haydn T. Jones, et al.. (2008). Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 158–162. 15 indexed citations
8.
Yeates, Clive, Alan T. Hudson, Mary Pudney, et al.. (2008). Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials. Journal of Medicinal Chemistry. 51(9). 2845–2852. 106 indexed citations
9.
Gellibert, Françoise, Anne‐Charlotte de Gouville, James M. Woolven, et al.. (2006). Discovery of 4-{4-[3-(Pyridin-2-yl)-1H-pyrazol-4-yl]pyridin-2-yl}-N-(tetrahydro-2H- pyran-4-yl)benzamide (GW788388):  A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor. Journal of Medicinal Chemistry. 49(7). 2210–2221. 86 indexed citations
10.
Warren, Gregory L., C. Webster Andrews, Brian Clarke, et al.. (2005). A Critical Assessment of Docking Programs and Scoring Functions. Journal of Medicinal Chemistry. 49(20). 5912–5931. 1339 indexed citations breakdown →
11.
Gellibert, Françoise, James M. Woolven, Marie-Hélène Fouchet, et al.. (2004). Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors. Journal of Medicinal Chemistry. 47(18). 4494–4506. 166 indexed citations
12.
13.
Borthwick, Alan D., Peter Ertl, Anne M. Exall, et al.. (2001). Design and Synthesis of Pyrrolidine-5,5-trans-lactams (5-Oxohexahydropyrrolo[3,2-b]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality. Journal of Medicinal Chemistry. 45(1). 1–18. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian D. Wall Breakdown of academic impact, for papers by Pieter F. W. Stouten Breakdown of academic impact, for papers by Alexander Hillisch Breakdown of academic impact, for papers by Natasja Brooijmans Breakdown of academic impact, for papers by Renée L. DesJarlais Breakdown of academic impact, for papers by Oliver Korb Breakdown of academic impact, for papers by Anne Cleasby Breakdown of academic impact, for papers by Olivier Spérandio Breakdown of academic impact, for papers by Gianni Chessari Breakdown of academic impact, for papers by Peichen Pan
Rankless by CCL
2026